Both Oxurion and Prevent Blindness join forces during November to educate the public on risk factors, symptoms, treatment options, and financial assistance resources.
“Partnerships with the industry and biotech companies like Oxurion are crucial to us,” says Jeff Todd, President & CEO of Prevent Blindness US.
“In those parts of the world there are many patients who lack access to routine retinal care,” Dr. Agrawal explains. “We aim to provide clinical care by sending retina ...
“Our key ambition is to put an end to avoidable blindness worldwide,” says Isabelle Verhaegen, Director of Light for the World. “Creating awareness of eye diseases really is ...
“There is currently an explosion in R&D activities in the retinal space. Numerous potential new therapies are ready for translation into clinical studies, making this a truly ...